More efficient inhalation

FAVORITE is Activaero's innovative technology for inhalation - the only technology that actively regulates inspiration flow as well as inhalation volume. Optimal inhalation patterns can thus be guided and controlled according to therapeutic requirements and the patient's individual condition. The drug can thus be delivered to the patient's lungs in an optimal manner and unwanted deposition in the throat is minimized.

FAVORITE offers clear advantages in comparison to conventional, non-active controlled inhalation:

  • Significantly improved utilization of the drug.

  • Better reproducibility of lung dosage.

Precise drug targeting

With FAVORITE Inhalation, Activaero was able to realize a significant advantage of aerosol therapy: precise and disease-tailored "Drug Targeting" to pre-defined regions in the lungs via controlled regulation of aerosolized drugs and air boluses.

  • Precise "Drug Targeting" with FAVORITE Inhalation", e.g. to  the small airways.

Improved inhalation systems

Patients with pulmonary disease generally have variable and sub-optimal breathing patterns, which can negatively affect lung deposition. Thus, the consistent and reproducible lung dosing of aerosolized drugs becomes a challenge.

Scintigraphic image of lung deposition following drug inhalation


When combined with AKITA® inhalation systems, FAVORITE Inhalation makes optimal drug delivery possible. Activaero's technology features controlled regulation of a patients' inhalation pattern and is specifically adapted to his or her individual breathing capacity. Optimal inhalation patterns can thus be guided and controlled according to therapeutic requirements and individual conditions.

    AKITA® JET

  • "The reference class for jet nebulizers"

AKITA2 APIXNEBTM

  • A revolution in drug use efficiency"